Cytotoxic drugs for non-neoplastic disease.
作者信息
Whitehouse J M
出版信息
Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):79-80. doi: 10.1136/bmj.287.6385.79.
Abstract
摘要
相似文献
1
Cytotoxic drugs for non-neoplastic disease.用于非肿瘤性疾病的细胞毒性药物。
Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):79-80. doi: 10.1136/bmj.287.6385.79.
2
Treatment of rheumatoid arthritis with cytotoxic and antimetabolic drugs.
Trans St Johns Hosp Dermatol Soc. 1970;56(2):117-21.
3
[The secondary disease in hematology and induced by antineoplastic chemotherapy].[血液学中的继发性疾病及抗肿瘤化疗所致]
Int J Clin Pharmacol. 1973 Dec;8(4):269-81.
4
[Therapy using cytostatics. Desired and undesired effects].
Fortschr Med. 1973 Nov 8;91(31):1218-22.
5
Proceedings: The effect of immunosuppression on cancer.会议论文集：免疫抑制对癌症的影响
Proc Natl Cancer Conf. 1972;7:425-36.
6
Rheumatoid arthritis VII: treatment with cytotoxic agents.类风湿关节炎VII：细胞毒性药物治疗
Md State Med J. 1982 Nov;31(11):51-2.
7
Topical lomustine in the treatment of psoriasis.
Arch Dermatol. 1972 Aug;106(2):172-6.
8
[Acute multisystemic bone marrow failure in the course of rheumatoid arthritis treated with gold salts].[类风湿关节炎患者在接受金盐治疗过程中发生的急性多系统骨髓衰竭]
Wiad Lek. 1970 Nov 15;23(22):2005-8.
9
Severe secondary bone marrow aplasia due to methotrexate in a patient with late onset rheumatoid arthritis.一名迟发性类风湿关节炎患者因甲氨蝶呤导致严重继发性骨髓再生障碍。
Reumatol Clin. 2014 Sep-Oct;10(5):344-5. doi: 10.1016/j.reuma.2014.02.013. Epub 2014 Jul 11.
10
Immuno suppressive drugs in rheumatoid arthritis-toxicity.类风湿关节炎中的免疫抑制药物——毒性
Adv Clin Pharmacol. 1974;6:98-104.
本文引用的文献
1
Systemic lupus erythematosus complicated by acute pulmonary hemorrhage: recovery following plasmapheresis and cytotoxic therapy.
J Rheumatol. 1981 Nov-Dec;8(6):1021-3.
2
Plasmapheresis as a guide for azathioprine therapy in prednisone-resistant myasthenia gravis.
Muscle Nerve. 1981 Nov-Dec;4(6):529-30. doi: 10.1002/mus.880040611.
3
Azathioprine therapy in the management of persistent erythema multiforme.硫唑嘌呤疗法用于治疗持久性多形红斑。
Br J Dermatol. 1981 Oct;105(4):465-7. doi: 10.1111/j.1365-2133.1981.tb00780.x.
4
Treatment of thrombotic thrombocytopenic purpura with vincristine.用长春新碱治疗血栓性血小板减少性紫癜。
JAMA. 1982 Mar 12;247(10):1433-6.
5
Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone.
Arch Intern Med. 1982 Aug;142(8):1445-7. doi: 10.1001/archinte.142.8.1445.
6
A longitudinal study on the effects of azathioprine and high doses of prednisone on the immune system of kidney-transplant recipients.一项关于硫唑嘌呤和高剂量泼尼松对肾移植受者免疫系统影响的纵向研究。
Clin Immunol Immunopathol. 1982 Jul;24(1):33-46. doi: 10.1016/0090-1229(82)90086-1.
7
Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients.硫唑嘌呤治疗多发性硬化症。一项为期4年半、涵盖115名患者的有效性对照研究的最终结果。
J Neurol Sci. 1982 Jun;54(3):377-94. doi: 10.1016/0022-510x(82)90201-5.
8
Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide.大剂量静脉注射环磷酰胺逆转系统性红斑狼疮继发的再生障碍性贫血
Br Med J (Clin Res Ed). 1982 Sep 18;285(6344):769-70. doi: 10.1136/bmj.285.6344.769.
9
Controlled trial of azathioprine in chronic ulcerative colitis.硫唑嘌呤治疗慢性溃疡性结肠炎的对照试验。
Br Med J (Clin Res Ed). 1982 May 1;284(6325):1291-2. doi: 10.1136/bmj.284.6325.1291.
10
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.进展性多发性硬化症的强化免疫抑制治疗。一项关于大剂量静脉注射环磷酰胺、血浆置换和促肾上腺皮质激素的随机三臂研究。
N Engl J Med. 1983 Jan 27;308(4):173-80. doi: 10.1056/NEJM198301273080401.
Zotero 插件